Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry-Reference-Cited by-同舟云学术

Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry

Published:2024-10 Issue:5 Volume:22 Page:102126
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Cortes Julian A.,Saitta Cesare^ORCID,Yuen Kit L.^ORCID,Patil Dattatraya,Tanaka Hajime^ORCID,Puri Dhruv^ORCID,Afari Jonathan A.^ORCID,Mahmood Mirha^ORCID,Matian Joshua,Mansour Mariam,Ahdoot Aaron^ORCID,Wang Luke,Meagher Margaret F.,Guer Melis,Dabbas Mai,Nguyen Mimi V.,Cerrato Clara,Kobayashi Masaki,Fukuda Shohei^ORCID,Fujii Yasuhisa,Master Viraj,Derweesh Ithaar H.^ORCID

Publisher

Elsevier BV

Reference30 articles.

1. Renal cancer;Capitanio;Lancet,2016

2. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score;Iimura;J Urol,2009

3. Preoperative elevation of C-reactive protein is a predictor for adverse oncologic survival outcomes for renal cell carcinoma: analysis from the international marker consortium renal cancer (INMARC);Patel;Clin Genitourin Cancer,2021

4. Charlson comorbidity index: a critical review of clinimetric properties;Charlson;Psychother Psychosom,2022

5. Elevated preoperative C- reactive protein is associated with renal functional decline and non- cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC);Cotta;BJU Int,2021